About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 4,241–4,250 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 4,181 |
Construction Management and Economics CONSTR MANAG ECON |
0144-6193 1466-433X |
3.300 | 3.700 | Q2 | 134/316 | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD |
| 4,181 |
CONTEMPORARY PHYSICS CONTEMP PHYS |
0010-7514 1366-5812 |
3.300 | 5.300 | Q2 | 30/114 | TAYLOR & FRANCIS LTD |
| 4,181 |
Corporate Communications CORP COMMUN |
1356-3289 1758-6046 |
3.300 | 3.100 | Q2 | 134/316 | EMERALD GROUP PUBLISHING LTD |
| 4,181 |
CORTEX CORTEX |
0010-9452 1973-8102 |
3.300 | 3.500 | Q1 | 11/102 | ELSEVIER MASSON, CORP OFF |
| 4,181 |
Current Cardiology Reports CURR CARDIOL REP |
1523-3782 1534-3170 |
3.300 | 3.600 | Q2 | 64/230 | SPRINGER |
| 4,181 |
Current Fungal Infection Reports CURR FUNGAL INFECT R |
1936-3761 1936-377X |
3.300 | 2.200 | Q2 | 41/137 | SPRINGER |
| 4,181 |
CURRENT GENE THERAPY CURR GENE THER |
1566-5232 1875-5631 |
3.300 | 2.800 | Q2 | 65/191 | BENTHAM SCIENCE PUBL LTD |
| 4,181 |
Current Hematologic Malignancy Reports CURR HEMATOL MALIG R |
1558-8211 1558-822X |
3.300 | 2.900 | Q2 | 28/98 | CURRENT MEDICINE GROUP |
| 4,181 |
CURRENT PROBLEMS IN CARDIOLOGY CURR PROB CARDIOLOGY |
0146-2806 1535-6280 |
3.300 | 3.400 | Q2 | 64/230 | MOSBY-ELSEVIER |
| 4,181 |
CURRENT TOPICS IN MEDICINAL CHEMISTRY CURR TOP MED CHEM |
1568-0266 1873-4294 |
3.300 | 3.300 | Q3 | 38/72 | BENTHAM SCIENCE PUBL LTD |